Press Releases
09/20/2011: TheraVasc
Releases Phase I Trial Data Demonstrating Safety of Drug in
Diabetic Patients
09/19/2011: TheraVasc's
Clinical Trial of PAD Drug Shows Safety in Diabetic Patients
08/06/2011: Start-up
Stories: A Race for Better Healing Therapies
07/05/2011: Peripheral
Artery Disease Pill from TheraVasc Heading to Phase IIa
Trials
09/27/2010: Peripheral
Artery Disease Drug Developer TheraVasc Raises $1.8M
12/30/2009: JumpStart and Portal Capital Invest in TheraVasc
08/19/2009: Theravasc
Awarded “Most Promising Life Science Technology Company” at
Rice Alliance Life
Science
Venture Forum